Hypertension Trial, Recruiting (NCT05166954)

Hypertension Trial, Recruiting NCT05166954 Sponsor: Beijing Friendship Hospital Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT05166954 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People between 18 and 70 years old
People with a Body Mass Index (BMI) above 24 kg/m² (a measure of body weight relative to height)
People who are patients at Beijing Friendship Hospital scheduled for weight-loss (bariatric) surgery
People who have been diagnosed with high blood pressure and have been taking two or more blood pressure medications for at least 4 weeks
People who are able to provide written consent to participate

Who may not be able to join:

People whose high blood pressure is caused by another underlying condition, unless that condition is sleep apnea
People who have had a serious heart or blood vessel event — such as a heart attack, heart failure, stroke, or a procedure to restore blood flow to the heart — within the past 6 months
People who have serious ongoing illnesses, including autoimmune diseases, cancer, advanced liver disease, serious breathing conditions, or serious digestive conditions
People who are unable to understand or follow the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rongchong Huang, M.D., Beijing Friendship Hospital

Phone: +86-13811039417

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05166954

Sponsor: Beijing Friendship Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: +86-13811039417

More information: https://clinicaltrials.gov/study/NCT05166954

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People between 18 and 70 years old
People with a Body Mass Index (BMI) above 24 kg/m² (a measure of body weight relative to height)
People who are patients at Beijing Friendship Hospital scheduled for weight-loss (bariatric) surgery
People who have been diagnosed with high blood pressure and have been taking two or more blood pressure medications for at least 4 weeks
People who are able to provide written consent to participate

Who may not be able to join:

People whose high blood pressure is caused by another underlying condition, unless that condition is sleep apnea
People who have had a serious heart or blood vessel event — such as a heart attack, heart failure, stroke, or a procedure to restore blood flow to the heart — within the past 6 months
People who have serious ongoing illnesses, including autoimmune diseases, cancer, advanced liver disease, serious breathing conditions, or serious digestive conditions
People who are unable to understand or follow the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Beijing Friendship Hospital

Registry

ClinicalTrials.gov

Start date

1 August 2018

Est. completion

31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Changes on left ventricular ejection fraction (LVEF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov